XOMAP FY 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$53M+847.0% YoY

Gross Profit

$45M85.1% margin

Operating Income

$17M32.3% margin

Net Income

$15M27.7% margin

EPS (Diluted)

$0.73

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$45M

Total Liabilities

$39M

Stockholders' Equity

$6M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$53M	$6M	+847.0%
Gross Profit	$45M	$4M	+976.2%
Operating Income	$17M	-$62M	+127.7%
Net Income	$15M	-$54M	+127.3%